Gainers
- Compass Pathways CMPS shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the press release, Q3 earnings came out today.
- Sonoma Pharmaceuticals SNOA shares increased by 14.31% to $6.63. The company's market cap stands at $17.8 million.
- Erytech Pharma ERYP shares increased by 12.49% to $2.79. The company's market cap stands at $77.8 million.
- Compass Therapeutics CMPX shares moved upwards by 10.96% to $4.15. The company's market cap stands at $256.0 million.
- DermTech DMTK stock rose 7.69% to $31.5. The company's market cap stands at $932.7 million. As per the news, the Q3 earnings report came out today.
- Inovio Pharmaceuticals INO stock increased by 7.27% to $7.23. The company's market cap stands at $1.5 billion. The company's, Q3 earnings came out today.
Losers
- SmileDirectClub SDC stock decreased by 24.77% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $1.5 billion. As per the news, the Q3 earnings report came out yesterday.
- Biohaven Pharma Hldgs BHVN shares declined by 14.15% to $120.0. The market value of their outstanding shares is at $7.8 billion. The company's, Q3 earnings came out today.
- Invitae NVTA shares decreased by 10.28% to $23.57. The market value of their outstanding shares is at $5.1 billion. As per the press release, Q3 earnings came out yesterday.
- Vericel VCEL stock declined by 7.2% to $40.0. The market value of their outstanding shares is at $1.8 billion. As per the press release, Q3 earnings came out today.
- Haemonetics HAE stock declined by 6.44% to $66.55. The market value of their outstanding shares is at $3.3 billion. The company's, Q2 earnings came out today.
- Artelo Biosciences ARTL stock decreased by 5.56% to $1.02. The company's market cap stands at $24.9 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in